Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-44.62%
↑ 59% above average
Average (8y)
-107.77%
Historical baseline
Range
High:50.24%
Low:-419.19%
Volatility
-435.6%
Relatively stable
| Period | Value |
|---|---|
| 2024 | -44.62% |
| 2023 | -5.40% |
| 2022 | -22.10% |
| 2021 | -419.19% |
| 2020 | 50.24% |
| 2019 | -165.88% |
| 2018 | -393.60% |
| 2017 | 30.64% |
| 2016 | 0.00% |